MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-12669

  1. 648 Posts.
    lightbulb Created with Sketch. 319
    wow, clinical remission by 6 weeks in all patients.

    interim analysis, olny 4 treated so far of planned 24. article doesn't state from which dosage cohort but who cares.

    https://academic.oup.com/ecco-jcc/article/16/Supplement_1/i398/6512925?login=false
    https://hotcopper.com.au/data/attachments/4024/4024814-b17528bd0afabd7545b7eb7069495032.jpg
    https://hotcopper.com.au/data/attachments/4024/4024817-2cc7232e3a3a6bd49c6f3782edc8eeff.jpg
    https://hotcopper.com.au/data/attachments/4024/4024820-6f4fe7b581a038b7d86da0eadf75836a.jpg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.